Benzamide, 5-chloro-2-hydroxy-N-[3-(trifluoromethyl)phenyl]- manufacturers
|
| | Benzamide, 5-chloro-2-hydroxy-N-[3-(trifluoromethyl)phenyl]- Basic information |
| | Benzamide, 5-chloro-2-hydroxy-N-[3-(trifluoromethyl)phenyl]- Chemical Properties |
| Melting point | 193-194 °C(Solv: ethanol (64-17-5)) | | Boiling point | 338.2±42.0 °C(Predicted) | | density | 1.487±0.06 g/cm3(Predicted) | | pka | 7.67±0.43(Predicted) |
| | Benzamide, 5-chloro-2-hydroxy-N-[3-(trifluoromethyl)phenyl]- Usage And Synthesis |
| Uses | SARS-CoV-2-IN-15 (compound 11) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.49 μM. SARS-CoV-2-IN-15 is a niclosamide analogue. SARS-CoV-2-IN-15 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1]. | | References | [1] Juang YP, et al. Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2. Eur J Med Chem. 2022 May 5;235:114295. DOI:10.1016/j.ejmech.2022.114295 |
| | Benzamide, 5-chloro-2-hydroxy-N-[3-(trifluoromethyl)phenyl]- Preparation Products And Raw materials |
|